To further investigate whether the expression level of FBXO31 was correlated the clinicopathological variables and patients' survival, we carried out immunohistochemical analyses of the tissue array including 90 paired paraffin-embedded GC and matched non-cancerous tissue. This evidence concerns the gene FBXO31 and gastric cancer.